In conclusion, this study delineated global hypomethylation and hypohydroxymethylation in the PBMCs of SLE patients and demonstrated, for the first time, that methylation of the TET2 gene during SLE development and its mRNA expression are correlated with disease activity. This evidence concerns the gene TET2 and systemic lupus erythematosus.